Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2011-02-22
2011-02-22
Bausch, Sarae (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091100, C436S063000
Reexamination Certificate
active
07892735
ABSTRACT:
The invention includes method of determining if a subject is at risk for developing schizophrenia (SZ), schizotypal personality disorder (SPD), or schizoaffective disorder (SD).
REFERENCES:
patent: 5474796 (1995-12-01), Brennan et al.
patent: 6274352 (2001-08-01), Schofield et al.
patent: 2005/0209181 (2005-09-01), Akil et al.
patent: 1 209 229 (2002-05-01), None
patent: WO 0078921 (2000-12-01), None
patent: WO 0180720 (2001-11-01), None
patent: WO03/102587 (2003-12-01), None
patent: WO 2004006838 (2004-01-01), None
Riley et al., Eur. J. Human Genetics (2006), 14:669-680.
Hegele et al. Arterioscler. Thromb. Vasc. Biol., 2002, vol. 22, pp. 1058-1061.
Hattersley et al. Lancet, 2005, vol. 366, pp. 1315-1323.
Ionnidis Plost Med, 2005, 2(8):e124.
Kroese et al. Genetics in Medicine, vol. 6 (2004), p. 475-480.
GeneCard, SULT4a1, pp. 1-13, available at www.genecard.com.
Mummidi et al., J. Biol. Chem, 2000, vol. 275, pp. 18946-18961.
Wall et al., Nature Genetics, 2003, vol. 4, p. 587-597.
The dbSNP Build Process, SNP FAQ Archive, p. 1, available at www.ncbi.nlm.nih.gov.
Brennan and Condra, “Transmission disequilibrium suggests a role for the sulfotransferase-4A1 gene in schizophrenia,” Am. J. Med. Genet. Part B (Neuropsych. Genet.) 139B:69-72 (2005).
Bulayeva et al., “Mapping genes of complex psychiatric diseases in Daghestan genetic isolates,” Am. J. Med. Genet. 6, 132B(1):76-84 (2004).
Chen et al., “Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families,” Mol. Psych. 9:962-7 (2004).
Clayton, “A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission,” Am. J. Hum. Genet. 65(4):1170-7 (1999).
Cloninger et al., “Genome-wide search for schizophrenia susceptibility loci: The NIMH genetics initiative and millennium consortium,” Am. J. Med. Genet. 81:275-281 (1998).
Condra et al., “Evidence for two schizophrenia susceptibility genes on chromosome 22q13,” Psych. Genet. 17(5):292-298 (2007).
Coon et al., “Genomic scan for genes predisposing to schizophrenia,” Am. J. Med. Genet. 54(1):59-71 (1994).
DeLisi et al., “A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder,” Am. J. Psych. 159:803-12 (2002).
Devaney et al., “No missense mutation of WKL1 in a subgroup of probands with schizophrenia,” Mol. Psych. 7:419-423 (2002).
Ewald and Lundorf, “The missense mutation in the WKL1 gene not found in patients with bipolar affective disorder,” Mol. Psych. 7:340-341 (2002).
Falany et al., “Molecular cloning and expression of novel sulphotransferase-like cDNAs from human and rat brain,” Biochem. J. 346:857-64 (2000).
Fallin et al., “Bipolar I disorder and schizophrenia: A 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios,” Am. J. Hum. Genet. 77:918-936 (2005).
Fanous and Kendler, “The genetic relationship of personality to major depression and schizophrenia,” Neurotox. Res. 6:43-50(2004).
Georgieva et al., “Genetic variation in the seven-pass transmembrane cadherin CELSR: Lack of association with schizophrenia,” Psych. Genet. 13:103-6 (2003).
Gill et al., “A combined analysis of D22S278 marker alleles in affected sib-pairs: Support for a susceptibility locus for schizophrenia at chromosome 22q12,” Schizophrenia Collaborative Linkage Group (Chromosome 22), Am. J. Med. Genet. 16:40-5 (1996).
Handoko et al., “Separate and interacting effects within the catechol-o-methyltransferase (COMT) are associated with schizophrenia,” Mol. Psych. 10:589-597 (2005) [Epub ahead of print Oct. 26, 2004].
Ivanov et al., “Chromosome 22q11 deletions, velo-cardio-facial syndrome and early-onset psychosis,” Molecular genetic study. Br. J. Psych. 183:409-13 (2003).
Jorgensen et al., “Search for common haplotypes on chromosome 22q in patients with schizophrenia or bipolar disorder from the Faroe Islands,” Am. J. Med. Genet. (Neuropsych. Genet.) 114:245-252 (2002).
Kaganovich et al., “Is the WKL1 gene associated with schizophrenia?” Am. J. Med. Genet. 125B:31-7 (2004).
Kaufmann et al., “NIMH genetics initiative millennium schizophrenia consortium: Linkage analysis of African-American pedigrees,” Am. J. Genet. 81:282-289 (1998).
Kelsoe et al., “A genome survey indicates a possible susceptibility locus for bipolar disorder on chromosome 22,” Proc. Natl. Acad. Sci. USA 98:585-90 (2001).
Lewis et al., “Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia,” Am. J. Hum. Genet. 73:34-48 (2003).
Li et al., “Evidence for association between novel polymorphisms in the PRODH gene and schizophrenia in a Chinese population,” Am. J. Med. Genet. 129B:13-5 (2004).
Liu et al., “Genetic variation at the 22q11 PRODH2/DGCR6 locus presents an unusual pattern and increases susceptibility to schizophrenia,” Proc. Natl. Acad. Sci. USA 99:3717-22 (2002).
Liyou et al., “Localization of a brain sulfotransferase, SULT4A1, in the human and rat brain: An immunohistochemical study,” J. Histochem. Cytochem. 51:1655-64 (2003).
Matise et al., “Systematic evaluation of map quality: Human chromosome 22,” Am. J. Hum. Genet. 70:1398-410 (2002).
Maziade et al., “A search for specific and common susceptibility loci for schizophrenia and bipolar disorder: A linkage study in 13 target chromosomes,” Mol. Psych. 6:684-93 (2001).
McGuffin et al., “Linkage and association studies of schizophrenia,” Curr. Psych. Rep. 5:121-7 (2003).
McQuillin et al., “A novel polymorphism in exon 11 of the WKL1 gene, shows no association with schizophrenia,” Eur. J. Hum. Gen. 10:491-494 (2002).
Meyer et al., “A missense mutation in a novel gene encoding a putative cation channel is associated with catatonic schizophrenia in a large pedigree,” Mol. Psych. 6:302-6 (2001).
Meyer et al., “Association of WKL1/MLC1 with catatonic schizophrenia,” Mol. Psych. 7:1037-38 (2002).
Mowry et al., “Multicenter linkage study of schizophrenia loci on chromosome 22q,” Mol. Psych. 9(8):784-795 (2004).
Murphy, “Cognitive deficits associated with schizophrenia in velo-cardio-facial syndrome,” Schizophr. Res. 70:223-32 (2004).
Myles-Worsley et al., “Linkage of a composite inhibitory phenotype to a chromosome 22q locus in eight Utah families,” Am. J. Med. Genet. (Neuropsych. Genet.) 88:544-550 (1999).
Polymeropoulos et al., “Search for a schizophrenia susceptibility locus on human chromosome 22,” Am. J. Med. Genet. 54:93-9 (1994).
Sakakibara et al., “Highly conserved mouse and human brain sulfotransferases: Molecular cloning, expression, and functional characterization,” Gene 285:39-47 (2002).
Sanders et al., “Haplotypic association spanning the 22q11.21 genes COMT and ARVCF with schizophrenia,” Mol. Psych. 10(4):353-65 (2004).
Severinsen et al., “Evidence implicating BRD1 with brain development and susceptibility to both schizophrenia and bipolar affective disorder,” Mol. Psych. 11(12):1126-1138 (2006).
Shifman et al., “A highly significant association between a COMT haplotype and schizophrenia,” Am. J. Hum. Genet. 71:1296-302 (2002).
Shirts and Nimgaonkar, “The genes for schizophrenia: Finally a breakthrough?” Curr. Psych. Rep. 6:303-12 (2004).
Stober et al., “Linkage and family-based association study of schizophrenia and the synapsin III locus that maps to chromosome 22q13,” Am. J. Med. Genet. 96(3):392-397 (2000).
Stober et al., “Splitting schizophrenia: Periodic catatonia-susceptibility locus on chromosome 15q15,” Am. J. Hum. Genet. 67:1201-1207 (2000).
Takahashi et al.,
Brennan Mark David
Condra Jodi Ann
Massey Amy Tabb
Neibergs Holly
Wei Wei
Bausch Sarae
Fish & Richardson P.C.
University of Louisville Research Foundation Inc.
LandOfFree
Genetic markers of schizophrenia spectrum disorders in the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Genetic markers of schizophrenia spectrum disorders in the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Genetic markers of schizophrenia spectrum disorders in the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2640622